GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.2487 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.2487 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, BCL2, CA12, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FABP3, FABP4, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TNKS, TNKS2, XDH |
12.7872 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
9.65825 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
8.94948 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
8.46298 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, FABP3, FABP4, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
8.45555 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD3, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, PTGS2 |
7.72418 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.7179 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.18257 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1 |
6.91209 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2C |
6.88637 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.7726 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.75184 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, PIK3CA, PIK3CB, PTGS1, PTGS2 |
6.46887 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
6.33415 |
[BP] GO:0050795 |
None
|
CNR1, DRD3, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
6.33415 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.25539 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.25539 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, HSD11B2, HTR1B, HTR5A, PTGS2 |
6.02157 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, CNR1, CNR2, DRD1, DRD3, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB |
5.98787 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1 |
5.92047 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, FABP3, FABP4, HSD11B2, HTR1B, HTR5A, MMP2, PIK3CA, PPARA, PTGS2 |
5.92047 |
[BP] GO:0007193 |
None
|
DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.91324 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, BCL2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
5.8965 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, BCL2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
5.89408 |
[BP] GO:0097746 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.89408 |
[BP] GO:0035296 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.89408 |
[BP] GO:0050880 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.68836 |
[BP] GO:0035150 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.67214 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, CA12, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HTR2B, HTR2C, PIK3CA, PPARA, PTGS1, PTGS2, XDH |
5.64682 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.45486 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
5.43209 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA7, CNR1, DRD1, DRD3, HTR2A, HTR2B, HTR2C, PIK3CB, PTGS2, TNKS, TNKS2 |
5.42811 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALPL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, F3, FABP4, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, MMP1, MMP2, MMP9, PIK3CA, PPARA, PTGS2, TNKS2 |
5.42142 |
[BP] GO:0007268 |
None
|
DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.38951 |
[BP] GO:0098916 |
None
|
DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.38951 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.33186 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, PTGS2 |
5.33186 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.27298 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.26606 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD3, HTR1B, HTR1D |
5.20436 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.16103 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
5.12991 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
5.08729 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
5.07351 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, BCL2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, TNKS2, XDH |
5.06766 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, HTR1B, HTR2A, PTGS2 |
5.02832 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, BCL2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, TNKS2, XDH |
4.96907 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2 |
4.94457 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA7, CNR1, DRD1, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
4.82882 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD3, ESR1, F3, FABP3, FABP4, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
4.71936 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, MMP2, PPARA, PTGS2 |
4.63088 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.51461 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.46575 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD3, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
4.44162 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD3, HTR1B, HTR2A, MMP9, PTGS2 |
4.38779 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
4.38556 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA4, CA7, CA9 |
4.38104 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA7, CNR1, CNR2, DRD1, DRD3, HTR1B, HTR2A, PTGS2 |
4.34799 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA7, CNR1, CNR2, DRD1, DRD3, HTR1B, HTR2A, PTGS2 |
4.34799 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.2737 |
[BP] GO:0006939 |
None
|
DRD1, HTR1D, HTR2A, HTR2B, HTR7 |
4.21894 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD3, HTR1A |
4.21894 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA7, CNR1, DRD1, DRD3, PIK3CB, PTGS2, TNKS, TNKS2 |
4.21894 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CNR1, CSNK2A1, CYP1B1, DRD3, F3, FABP4, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
4.17557 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.17232 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
4.12538 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1 |
4.11612 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, ESR1, F3, FABP4, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, TNKS, TNKS2, XDH |
4.10393 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD3, ESR1, F3, FABP3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS1, PTGS2, XDH |
4.04837 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, HTR1B, HTR2A, PTGS2 |
3.81973 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.79968 |
[BP] GO:0007154 |
None
|
BCL2, CNR1, DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
3.74888 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, DRD3, FABP3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.74714 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1 |
3.73969 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
3.6958 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS2 |
3.67562 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.67068 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, BCL2, CA7, CNR1, DRD1, DRD3, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
3.67068 |
[BP] GO:0014059 |
None
|
CNR1, DRD3, HTR1B, HTR2A |
3.64348 |
[BP] GO:0003008 |
None
|
AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2 |
3.64024 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.57576 |
[BP] GO:0007267 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.5656 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.54028 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.54028 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
3.52868 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
3.52776 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
3.4916 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA7, CNR1, CNR2, HTR1B |
3.44468 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.44468 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA7, DRD1, DRD3, HTR2A, HTR2B, HTR2C |
3.42703 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR2A |
3.36182 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
3.36182 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.3594 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, BCL2, CA7, CNR1, CYP19A1, DRD1, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
3.35233 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA7, DRD1, DRD3, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
3.34051 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA4, CA7, CA9, DRD3, FABP3, PPARA |
3.33661 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD3, HTR1A |
3.3216 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, F3, HTR2A, HTR2B, HTR2C, HTR6, PIK3CA, PIK3CB, PTGS2, XDH |
3.28891 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA4, CA7, CA9 |
3.27244 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD3, ESR1, F3, FABP3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, TNKS, TNKS2, XDH |
3.25744 |
[BP] GO:0032845 |
None
|
BCL2, HTR2A, HTR2B, HTR2C, TNKS, TNKS2 |
3.2529 |
[BP] GO:0002031 |
None
|
DRD3, HTR1B, HTR2B |
3.25281 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.25281 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.19448 |
[BP] GO:0023052 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.19448 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD3, ESR1, F3, FABP3, FABP4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, TNKS, TNKS2, XDH |
3.18534 |
[BP] GO:0008217 |
None
|
CNR1, DRD3, HSD11B2, PPARA, PTGS1, PTGS2 |
3.18496 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, DRD1, DRD3, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
3.13263 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, BCL2, CA12, CA7, CNR1, DRD1, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.131 |
[BP] GO:0007200 |
None
|
DRD1, ESR1, HTR2A, HTR2B, HTR2C |
3.12566 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, DRD1, DRD3, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
3.09429 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD3, HTR1B, HTR2A |
3.08269 |
[BP] GO:0051588 |
None
|
DRD1, DRD3, HTR1A, HTR1B, HTR2C |
3.06162 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, MMP9, PTGS2 |
3.03702 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C |
3.00415 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.95749 |
[BP] GO:0032787 |
None
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
2.92987 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD3, ESR1, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.90637 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD3, FABP3, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
2.88906 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.87459 |
[BP] GO:0050433 |
None
|
CNR1, DRD3, HTR1B, HTR2A |
2.87459 |
[BP] GO:0032225 |
None
|
DRD1, DRD3, PTGS2 |
2.79011 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.78275 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, DRD3, ESR1, F3, FABP4, PPARA, PTGS2, PTPRS |
2.78083 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.77608 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.75655 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD3, HTR1A |
2.75182 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, HTR1B, MMP2, MMP9, PIK3CA, PTGS2 |
2.73267 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA9, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FUT7, HSD11B1, HTR2A, HTR2B, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, TNKS2 |
2.73186 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.70527 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.69628 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, TNKS, TNKS2 |
2.68913 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.6664 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.6664 |
[BP] GO:0014821 |
None
|
DRD1, HTR1D, HTR2B |
2.66532 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3 |
2.64564 |
[BP] GO:0031623 |
None
|
ACHE, DRD3, HTR1B, HTR2B |
2.64475 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.63947 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD3, FABP3, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
2.63091 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA4, CA7, CA9, DRD3, FABP3, PPARA |
2.55473 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, BCL2, CYP1A1, DRD1, DRD3, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2 |
2.55473 |
[BP] GO:0048148 |
None
|
DRD1, DRD3, HTR2A |
2.54711 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.54371 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.49058 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.48769 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.43432 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.42928 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
2.42839 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, HTR1B, MMP2, PIK3CA, PTGS2 |
2.42307 |
[BP] GO:0006936 |
None
|
DRD1, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.42307 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.42307 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.41328 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38231 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.36893 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD3, PIK3CA, TNKS2 |
2.35393 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, BCL2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, HSD11B2, HTR1A, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
2.35393 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, BCL2, CA12, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FABP3, FABP4, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.34962 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.33972 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.33972 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.33972 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.31119 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA7 |
2.31119 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.31119 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.31119 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.31119 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, BCL2, CNR1, CNR2, CSNK2A1, DRD1, DRD3, ESR1, F3, FABP4, HTR2A, HTR2B, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, XDH |
2.28238 |
[BP] GO:1900543 |
None
|
DRD3, HTR1B, HTR1E, PPARA |
2.28185 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C |
2.26186 |
[BP] GO:0045980 |
None
|
DRD3, HTR1B, HTR1E, PPARA |
2.26186 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.26039 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD3 |
2.26039 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD3, ESR1, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PPARA, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.25828 |
[BP] GO:1900542 |
None
|
DRD1, DRD3, HTR1B, HTR1E, HTR2A, PPARA |
2.25828 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, DRD1, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.23256 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, DRD1, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.23256 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD3, HTR1B |
2.21973 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.21122 |
[BP] GO:0006140 |
None
|
DRD1, DRD3, HTR1B, HTR1E, HTR2A, PPARA |
2.19863 |
[BP] GO:0006811 |
None
|
ABCB1, CA12, CA14, CA4, CA7, CA9, DRD1, DRD3, FABP3, HTR2A, HTR2B, HTR2C, PPARA |
2.18305 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.18236 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.18236 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.17409 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.16714 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA12, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.15756 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA7, DRD1, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.15266 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.14664 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.13867 |
[BP] GO:0090407 |
organophosphate biosynthetic process
|
ACHE, ALOX15, CSNK2A1, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2 |
2.13276 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, HSD11B2, HTR1B, PTGS2 |
2.12376 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.11058 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD3, HTR1A, PTGS2 |
2.09035 |
[BP] GO:0042220 |
None
|
CNR1, DRD3, HTR1B |
2.07075 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2 |
2.05671 |
[BP] GO:0019217 |
None
|
CNR1, FABP3, PPARA, PTGS2 |
2.05281 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.04537 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CNR1, CNR2, CSNK2A1, CYP1B1, DRD3, ESR1, FABP4, MMP9, PPARA, PTGS2, TNKS |
2.03956 |
[BP] GO:0003012 |
None
|
DRD1, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.02144 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.00369 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B |
2.00369 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS, TNKS, TNKS2 |
5.45267 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, CA4, CNR1, CNR2, DRD1, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTPRS |
5.28769 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS |
5.1565 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, CA12, CA14, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTPRS |
4.4627 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, CNR1, CNR2, DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTPRS |
4.21894 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ALOX15, CA4, CA9, CNR1, CNR2, DRD1, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTGS2, PTPRS |
3.99257 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, HSD11B1, HSD11B2, PTGS1, PTGS2 |
2.26182 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA3, ALPL, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD3, ESR1, F3, FUT7, HSD11B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTPRS |
2.04988 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.2487 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.2487 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
17.835 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
17.835 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.8216 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
14.3588 |
[MF] GO:0030594 |
None
|
DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.9783 |
[MF] GO:0008227 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.8086 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
12.3285 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALPL, CA12, CA14, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, F3, FABP3, FABP4, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, TUBB3, XDH |
9.81637 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, CA12, CA14, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, TNKS, TNKS2, XDH |
7.18257 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA4, CA7, CA9 |
6.39356 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, CA12, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, TNKS, XDH |
6.33415 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
6.01012 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.92047 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
5.64865 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.60167 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.38036 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
4.97211 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.82882 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.82882 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
4.78767 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
4.63088 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
4.50968 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
4.44162 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, CNR1, CNR2, DRD1, DRD3, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
4.38779 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD3, HTR1B, HTR2A, HTR2B, HTR2C, NQO2, PIK3CA, PIK3CB, PPARA |
4.34947 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.34799 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
4.17232 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.09561 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA4, CA7, CA9 |
3.97 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, ALOX15, ALPL, CA12, CA14, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F3, FUT7, HSD11B1, HSD11B2, HSD17B1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, TUBB3, XDH |
3.64024 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.48708 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA4, CA7, CA9 |
3.38066 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD11B1, HSD11B2, HSD17B1, XDH |
3.36235 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.95749 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.95749 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.95749 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.95749 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.72945 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA4, CA7, CA9, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, TNKS |
2.6664 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, CBR1, HSD11B1, HSD11B2, HSD17B1 |
2.55473 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.55473 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.55473 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.55473 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.31119 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.31119 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1 |
2.21973 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1 |
2.14664 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.13867 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, HSD11B2, HSD17B1 |
2.02144 |